We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Expose Companies’ Noncompliance With Pediatric Trial Requirements
FDA to Expose Companies’ Noncompliance With Pediatric Trial Requirements
August 26, 2013
Drugmakers that fail to follow through on their pediatric clinical trial requirements may be outed as absconders by the FDA by having their non-compliance letters and company responses posted on the FDA’s website, the agency said Monday in a blog post.